[Google Scholar] 24.Zhang Y, Zhang L
Most patients report that by the end of week eight, side effects are negligible and they experience only the therapeutic benefit of sustained appetite control
The drug reaches a steady blood level in about four weeks, and most people do not hit their maintenance dosage until up to 21 weeks
These have helped people lose weight, feel more confident and be healthier
Health Topics page
Compounding when drugs are on FDAs drug shortages list, Food and Drug Administration (2024) FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, Food and Drug Administration (2025) Mounjaro, DailyMed (2024) Savings & resources, Eli Lilly and Company (2024) FDAs concerns with unapproved GLP-1 drugs used for weight loss, Food and Drug Administration (2024) FDA warns patients and health care professionals not to use compounded drugs from Fullerton Wellness, Food and Drug Administration (2024) An open letter from Eli Lilly and Company regarding certain practices related to Mounjaro and Zepbound, Eli Lilly (2024) Compounding and the FDA: Questions and answers, Food and Drug Administration (2024) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
